KTOV - started a position trade (3.30's) in this biotech today. It's an interesting story, since it's primary drug (NDA due in a few months) is a compound drug, and hence would save money -- a nice benefit for any administration looking to reduce the cost of pharma. Would like to add more shares closer to 3 (say, if Hillary wins).
Solid DD combined with timeliness and conviction is a recipe for profits.